Cite
APA Citation
El‐Naggar, A. M., Somasekharan, S. P., Wang, Y., Cheng, H., Negri, G. L., Pan, M., Wang, X. Q., Delaidelli, A., Rafn, B., Cran, J., Zhang, F., Zhang, H., Colborne, S., Gleave, M., Mandinova, A., Kedersha, N., Hughes, C. S., Surdez, D., Delattre, O., Wang, Y., Huntsman, D. G., Morin, G. B., & Sorensen, P. H. (2019). class I HDAC inhibitors enhance YB‐1 acetylation and oxidative stress to block sarcoma metastasis. EMBO reports, 20, n/a. http://access.bl.uk/ark:/81055/vdc_100098070127.0x000022